“The current predicament has exposed some structural weaknesses within the EU’s medicines offer chain plus a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She advisable that offer chain issues be resolved in an EU pharmaceutical tactic predicted being launched by the tip of y… Read More